The complexity of cardiolipin in health and disease

Trends in Biochemical Sciences

Volumn 37, Issue 1, 2012, Pages 32-41

  Claypool, Steven M ^a   Koehler, Carla M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; MONOLYSOCARDIOLIPIN ACYLTRANSFERASE 1; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDYLGLYCEROLPHOSPHATE PHOSPHATASE; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

CELL MEMBRANE; CELL ORGANELLE; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; EUKARYOTIC CELL; HUMAN; MITOCHONDRION; MOLECULAR MODEL; MORPHOLOGY; NONHUMAN; OUTER MEMBRANE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SEQUENCE HOMOLOGY;

CARDIOLIPINS; DISEASE; ENZYMES; HEALTH STATUS; HUMANS;

EID: 84855581252     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2011.09.003     Document Type: Review

References (79)

1. Gebert N., et al. Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome. Curr. Biol. 2009, 19:2133-2139.
2. Joshi A.S., et al. Cellular functions of cardiolipin in yeast. Biochim. Biophys. Acta 2009, 1793:212-218.
3. Osman C., et al. Making heads or tails of phospholipids in mitochondria. J. Cell Biol. 2011, 192:7-16.
4. Schlame M., Ren M. The role of cardiolipin in the structural organization of mitochondrial membranes. Biochim. Biophys. Acta 2009, 1788:2080-2083.
5. Sparagna G.C., Lesnefsky E.J. Cardiolipin remodeling in the heart. J. Cardiovasc. Pharmacol. 2009, 53:290-301.
6. Claypool S.M., et al. Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane. J. Cell Biol. 2008, 182:937-950.
7. Mileykovskaya E., Dowhan W. Cardiolipin membrane domains in prokaryotes and eukaryotes. Biochim. Biophys. Acta 2009, 1788:2084-2091.
8. Claypool S.M. Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim. Biophys. Acta 2009, 1788:2059-2068.
9. Houtkooper R.H., et al. Identification and characterization of human cardiolipin synthase. FEBS Lett. 2006, 580:3059-3064.
10. Houtkooper R.H., et al. The enigmatic role of tafazzin in cardiolipin metabolism. Biochim. Biophys. Acta 2009, 1788:2003-2014.
11. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J. Lipid Res. 2008, 49:1607-1620.
12. Schlame M., Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 2006, 580:5450-5455.
13. Schlame M., et al. Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids 2005, 138:38-49.
14. Cheng H., et al. Shotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodeling. Biochemistry 2008, 47:5869-5880.
15. Osman C., et al. A mitochondrial phosphatase required for cardiolipin biosynthesis: the PGP phosphatase Gep4. EMBO J. 2010, 29:1976-1987.
16. Zhang J., et al. Mitochondrial phosphatase PTPMT1 is essential for cardiolipin biosynthesis. Cell Metab. 2011, 13:690-700.
17. Osman C., et al. The genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria. J. Cell Biol. 2009, 184:583-596.
18. Pagliarini D.J., et al. Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells. Mol. Cell 2005, 19:197-207.
19. Xiao J., et al. Structural and functional analysis of PTPMT1, a phosphatase required for cardiolipin synthesis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11860-11865.
20. Schlame M., Haldar D. Cardiolipin is synthesized on the matrix side of the inner membrane in rat liver mitochondria. J. Biol. Chem. 1993, 268:74-79.
21. Beranek A., et al. Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeast. J. Biol. Chem. 2009, 284:11572-11578.
22. Houtkooper R.H., et al. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal. Biochem. 2009, 387:230-237.
23. Malhotra A., et al. Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2337-2341.
24. Mancuso D.J., et al. Genetic ablation of calcium-independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction. J. Biol. Chem. 2009, 284:35632-35644.
25. Mancuso D.J., et al. Genetic ablation of calcium-independent phospholipase A2gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype. J. Biol. Chem. 2007, 282:34611-34622.
26. Mancuso D.J., et al. Genetic ablation of calcium-independent phospholipase A2gamma prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation. J. Biol. Chem. 2010, 285:36495-36510.
27. Claypool S.M., et al. Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins. J. Cell Biol. 2006, 174:379-390.
28. Xu Y., et al. The enzymatic function of tafazzin. J. Biol. Chem. 2006, 281:39217-39224.
29. Malhotra A., et al. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species. Biochim. Biophys. Acta 2009, 1791:314-320.
30. Schlame M. Formation of molecular species of mitochondrial cardiolipin. 2. A mathematical model of pattern formation by phospholipid transacylation. Biochim. Biophys. Acta 2009, 1791:321-325.
31. Vaz F.M., et al. Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism. J. Biol. Chem. 2003, 278:43089-43094.
32. Rijken P.J., et al. Cardiolipin molecular species with shorter acyl chains accumulate in Saccharomyces cerevisiae mutants lacking the acyl coenzyme A-binding protein Acb1p: new insights into acyl chain remodeling of cardiolipin. J. Biol. Chem. 2009, 284:27609-27619.
33. Taylor W.A., Hatch G.M. Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J. Biol. Chem. 2003, 278:12716-12721.
34. Taylor W.A., Hatch G.M. Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1). J. Biol. Chem. 2009, 284:30360-30371.
35. Carpenter K., et al. Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound β-oxidation enzyme of mitochondria. Biochem. Biophys. Res. Commun. 1992, 183:443-448.
36. Fould B., et al. Structural and functional characterization of the recombinant human mitochondrial trifunctional protein. Biochemistry 2010, 49:8608-8617.
37. Brackett J.C., et al. Two α subunit donor splice site mutations cause human trifunctional protein deficiency. J. Clin. Invest. 1995, 95:2076-2082.
38. Cao J., et al. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J. Biol. Chem. 2004, 279:31727-31734.
39. Cao J., et al. ALCAT1 is a polyglycerophospholipid acyltransferase potently regulated by adenine nucleotide and thyroid status. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E647-E653.
40. Li J., et al. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab. 2010, 12:154-165.
41. Chicco A.J., Sparagna G.C. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am. J. Physiol. Cell Physiol. 2007, 292:C33-C44.
42. Lesnefsky E.J., et al. Enhanced modification of cardiolipin during ischemia in the aged heart. J. Mol. Cell. Cardiol. 2009, 46:1008-1015.
43. Saini-Chohan H.K., et al. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure. J. Lipid Res. 2009, 50:1600-1608.
44. Han X., et al. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry 2007, 46:6417-6428.
45. Kiebish M.A., et al. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J. Lipid Res. 2008, 49:2545-2556.
46. Yurkova I.L., et al. Fragmentation of mitochondrial cardiolipin by copper ions in the Atp7b(-/-) mouse model of Wilson's disease. Chem. Phys. Lipids 2011, 164:393-400.
47. Valianpour F., et al. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J. Lipid Res. 2005, 46:1182-1195.
48. Xu Y., et al. Characterization of tafazzin splice variants from humans and fruit flies. J. Biol. Chem. 2009, 284:29230-29239.
49. Claypool S.M., et al. The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome. Mol. Biol. Cell 2008, 19:5143-5155.
50. McKenzie M., et al. Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J. Mol. Biol. 2006, 361:462-469.
51. Brandner K., et al. Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth syndrome. Mol. Biol. Cell 2005, 16:5202-5214.
52. Acehan D., et al. Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria. Mitochondrion 2009, 9:86-95.
53. Acehan D., et al. Cardiolipin affects the supramolecular organization of ATP synthase in mitochondria. Biophys. J. 2011, 100:2184-2192.
54. Acehan D., et al. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J. Biol. Chem. 2011, 286:899-908.
55. Acehan D., et al. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Lab. Invest. 2007, 87:40-48.
56. Soustek M.S., et al. Characterization of a transgenic short hairpin RNA-induced murine model of tafazzin deficiency. Hum. Gene Ther. 2011, 22:865-871.
57. Chernomordik L.V., et al. Membranes of the world unite!. J. Cell Biol. 2006, 175:201-207.
58. Paumard P., et al. The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J. 2002, 21:221-230.
59. Chen S., et al. Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth. Mol. Microbiol. 2008, 68:1061-1072.
60. Tripodi A., et al. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. J. Intern. Med. 2011, 270:110-122.
61. Cox D., et al. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 2009, 4:e5325.
62. Dieude M., et al. Cardiolipin binds to CD1d and stimulates CD1d-restricted γδ T cells in the normal murine repertoire. J. Immunol. 2011, 186:4771-4781.
63. Ray N.B., et al. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat. Med. 2010, 16:1120-1127.
64. Choi S.Y., et al. A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat. Cell Biol. 2006, 8:1255-1262.
65. Gohil V.M., et al. Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine and cardiolipin biosynthetic pathways in Saccharomyces cerevisiae. J. Biol. Chem. 2005, 280:35410-35416.
66. Osman C., et al. Prohibitins and the functional compartmentalization of mitochondrial membranes. J. Cell Sci. 2009, 122:3823-3830.
67. Tamura Y., et al. Ups1p and Ups2p antagonistically regulate cardiolipin metabolism in mitochondria. J. Cell Biol. 2009, 185:1029-1045.
68. Potting C., et al. Regulation of mitochondrial phospholipids by Ups1/PRELI-like proteins depends on proteolysis and Mdm35. EMBO J. 2010, 29:2888-2898.
69. Tamura Y., et al. Mdm35p imports Ups proteins into the mitochondrial intermembrane space by functional complex formation. EMBO J. 2010, 29:2875-2887.
70. Dimmer K.S., et al. Mdm31 and Mdm32 are inner membrane proteins required for maintenance of mitochondrial shape and stability of mitochondrial DNA nucleoids in yeast. J. Cell Biol. 2005, 168:103-115.
71. Kornmann B., et al. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science 2009, 325:477-481.
72. Kuroda T., et al. FMP30 is required for the maintenance of a normal cardiolipin level and mitochondrial morphology in the absence of mitochondrial phosphatidylethanolamine synthesis. Mol. Microbiol. 2011, 80:248-265.
73. Kutik S., et al. The translocator maintenance protein Tam41 is required for mitochondrial cardiolipin biosynthesis. J. Cell Biol. 2008, 183:1213-1221.
74. Claypool S.M., et al. Barth syndrome mutations that cause tafazzin complex lability. J. Cell Biol. 2011, 192:447-462.
75. Haines T.H. A new look at Cardiolipin. Biochim. Biophys. Acta 2009, 1788:1997-2002.
76. Ban T., et al. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Hum. Mol. Genet. 2010, 19:2113-2122.
77. DeVay R.M., et al. Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusion. J. Cell Biol. 2009, 186:793-803.
78. Montessuit S., et al. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell 2010, 142:889-901.
79. Gonzalvez F., et al. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J. Cell Biol. 2008, 183:681-696.